Related Experiment Videos
[Chemotherapy risk assessment for elderly patients].
1Department of Oncology,PUMC Hospital,CAMS and PUMC,Beijing 100032,China.
Summary
Predicting chemotherapy toxicity is crucial for elderly cancer patients, as they are more prone to complications. This review covers recent risk assessment tools to aid in managing treatment for this population.
Area of Science:
- Geriatric oncology
- Clinical pharmacology
- Cancer treatment
Context:
- Cancer incidence rises with age, making elderly patients a significant demographic for chemotherapy.
- Elderly individuals often experience more severe complications from cytotoxic chemotherapy.
- Accurate prediction of treatment toxicity is essential for optimizing care in older adults.
Purpose:
- To review and summarize current chemotherapy risk assessment tools specifically designed for elderly cancer patients.
- To provide an overview of methods for predicting and managing chemotherapy-related toxicity in geriatric oncology.
Summary:
- This review consolidates information on recent advancements in chemotherapy risk assessment tools for the elderly.
- It highlights the importance of these tools in the context of age-related increases in cancer incidence and treatment complications.
Impact:
- Aims to improve treatment decisions and patient outcomes by facilitating better prediction of chemotherapy toxicity in elderly patients.
- Supports clinicians in selecting appropriate risk assessment strategies for geriatric cancer care.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
387
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
387
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
346
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
346
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
369
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
369
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
377
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
377
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
351
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
351
01:24Drug Toxicity: Risk factors
225
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
225